Bio 33 15 Mar 27 Bond Current Liabilities
| 090572AR9 | 93.40 3.51 3.62% |
BIO 33 15 MAR 27 fundamentals help investors to digest information that contributes to 090572AR9's financial success or failures. It also enables traders to predict the movement of 090572AR9 Bond. The fundamental analysis module provides a way to measure 090572AR9's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 090572AR9 bond.
090572AR9 |
BIO 33 15 MAR 27 Corporate Bond Current Liabilities Analysis
090572AR9's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
In accordance with the recently published financial statements, BIO 33 15 MAR 27 has a Current Liabilities of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Current Liabilities (which currently averages 0.0) industry. This indicator is about the same for all United States bonds average (which is currently at 0.0).
090572AR9 Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 090572AR9's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the bonds which would be a good addition to a portfolio. Peer analysis of 090572AR9 could also be used in its relative valuation, which is a method of valuing 090572AR9 by comparing valuation metrics of similar companies.BIO 33 cannot be rated in Current Liabilities category at this point.
About 090572AR9 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIO 33 15 MAR 27's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 090572AR9 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIO 33 15 MAR 27 based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in 090572AR9 Bond
090572AR9 financial ratios help investors to determine whether 090572AR9 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 090572AR9 with respect to the benefits of owning 090572AR9 security.